Growth & Innovation Summit

Unlocking Value in Late-Stage Life Sciences

Monday, November 17, 2025 | 8:15 AM - 18:30 PM

My countdown

Corinthia Hotel

Sponsored by

Whitehall Pl
London SW1A 2BD
United Kingdom

Mission

This event has been designed to foster connections between investors actively seeking opportunities and late-stage life science companies looking for investment and partnerships.

Schedule

Moderator: Adam Evertts, Managing Director, Director of Research - LifeSci Capital
Panelists:
Joe Anderson, Partner - Sofinnova Partners
Agustin Mohedas, Portfolio Manager & Research Analyst - Janus Henderson
Alex Rosen, Managing Partner - Spruce Street Capital
I-Hung Shih, Managing Director - Eventide
Steve Yang, Co-CEO - WuXi Apptec
Moderator:
Kinam Hong, Partner, Sofinnova Partners
Panelists:
Didier Blondel, CFO, Abivax
Gabe Cavazos, Senior Managing Director, Investment Banking, Leerink Partners
Divakar Gupta, Partner, Cooley LLP
Michael Rice, President & Co-Founder, LifeSci Capital
Speakers:
Catherine Arnold - Partner, Centerview
Henry Gosebruch – CEO, Galapagos
Michael Palladinetti - Global Head of Immunology & Inflammation Business Development, Sanofi
Matthias Muellenbeck - Senior VP, Head of Global Business Development & Alliance Management, Merck Healthcare KGaA
Chris Sheldon - Senior Vice President & Global Head of Business Development, GSK

Request to Participate

Session Topics

  
    8:15
    Registration and Breakfast
  
    9:15
    Sessions and One-to-one Meetings
  
    12:00
    Lunch
  
    13:30
    Sessions and One-to-one Meetings
  
    17:00
    Cocktail Reception

Who Will Attend?

The Growth & Innovation Summit is an invite-only event where the world’s leading late-stage investors connect with 35+ handpicked life sciences innovators. The selected companies—both public and private—represent a dynamic mix of leading European and international players. To request an invitation please email conference@lifescicapital.com.

200+ Total Attendees

35+ Companies

100+ Investors

170+ Confirmed Meetings

15+ Panelists

10+ Pharma Strategics

1 Exclusive Sponsor

200+ Total Attendees 35+ Companies 100+ Investors 170+ Confirmed Meetings 15+ Panelists 10+ Pharma Strategics 1 Exclusive Sponsor

2024 By The Numbers

One-to-One Meetings

The organizing team takes an active, hands-on approach to curate and coordinate one-to-one meetings, ensuring each conversation is purposeful, high-value, and aligned with your goals.